 Antistaphylococcal activities teicoplanin vancomycin vitro experimental infection efficacies vancomycin teicoplanin experimental Staphylococcus aureus infection granulocytopenic mice activities vitro pharmacokinetic profiles vitro teicoplanin intrinsic activity vancomycin favorable pharmacokinetic profile peak concentrations plasma elimination half-life area concentration-time curve vancomycin antibacterial efficacies drugs vivo basis activities vitro pharmacokinetics mathematical model model vitro effect difference growth rate control cultures presence antibiotic ER vivo effect difference numbers CFU control antibiotic-treated animals EN integral ER time ERt concentrations vivo significant linear relationship EN ERt different dosages times drug administration doses consecutive times doses teicoplanin observed effect predicted effect